Bio-Rad Laboratories, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Bio-Rad Laboratories, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 In Vitro Diagnostics 14
3.1.1 Genetic Testing 14
3.1.2 Haematology 14
3.1.3 Immuno Chemistry 14
3.1.4 Infectious Immunology 14
3.1.5 Microbiology Culture 14
4 Company Snapshot 15
4.1 Key Information 15
4.2 Company Overview 15
4.3 Financial Performance 15
4.4 SWOT Snapshot 15
5 Business Description 16
5.1 Business Overview 16
5.2 Clinical Diagnostics 16
5.2.1 Overview 16
5.2.2 Financials 16
5.2.3 Capital Expenditure 16
5.2.4 Market View 16
5.3 Life Sciences 17
5.3.1 Overview 17
5.3.2 Financials 17
5.3.3 Capital Expenditure 17
5.3.4 Market View 17
5.4 Major Products and Services 17
5.4.1 Overview 17
6 History 18
7 Business Strategy 21
7.1 Mission Statement 21
8 SWOT Analysis 22
8.1 Overview 22
8.2 Bio-Rad Laboratories, Inc. Strengths 22
8.2.1 Diversified Segments Served 22
8.2.2 Global Presence 22
8.2.3 Product Development Efforts 23
8.3 Bio-Rad Laboratories, Inc. Weaknesses 23
8.3.1 Low Debt to Equity Ratio 23
8.3.2 Product Recalls 23
8.4 Bio-Rad Laboratories, Inc. Opportunities 23
8.4.1 Inorganic Growth Drivers 23
8.4.2 Rising Healthcare Expenditure in the US 24
8.4.3 Growth in Emerging Economies 24
8.4.4 Potential Life Sciences Market 24
8.5 Bio-Rad Laboratories, Inc. Threats 24
8.5.1 Intense Competition 24
8.5.2 Stringent Government Regulations 24
8.5.3 Changing Diagnostic Market Conditions 25
9 Competitors 26
10 Competitive Landscape 28
10.1 In Vitro Diagnostics (Genetic Testing), Global, Market Share (%), 2011 28
10.2 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Region, Market Share (2011) 29
10.3 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Genetic Testing), by Country, Market Share (2011) 30
10.4 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 32
10.5 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 34
10.6 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 35
10.7 In Vitro Diagnostics (Immuno Chemistry), Global, Market Share (%), 2011 37
10.8 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Region, Market Share (2011) 39
10.9 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Immuno Chemistry), by Country, Market Share (2011) 40
10.10 In Vitro Diagnostics (Infectious Immunology), Global, Market Share (%), 2011 42
10.11 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Region, Market Share (2011) 44
10.12 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Infectious Immunology), by Country, Market Share (2011) 45
10.13 In Vitro Diagnostics (Microbiology Culture), Global, Market Share (%), 2011 47
10.14 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Region, Market Share (2011) 48
10.15 Bio-Rad Laboratories, Inc., In Vitro Diagnostics (Microbiology Culture), by Country, Market Share (2011) 49
11 Bio-Rad Laboratories, Inc. Medical Equipment Market Share Analysis 51
11.1 Bio-Rad Laboratories, Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 51
11.2 Bio-Rad Laboratories, Inc., Asia-Pacific, Category Revenue Share (2011) 53
11.2.1 Bio-Rad Laboratories, Inc., Australia, Category Revenue Share (2011) 55
11.2.2 Bio-Rad Laboratories, Inc., China, Category Revenue Share (2011) 57
11.2.3 Bio-Rad Laboratories, Inc., India, Category Revenue Share (2011) 59
11.2.4 Bio-Rad Laboratories, Inc., Japan, Category Revenue Share (2011) 61
11.2.5 Bio-Rad Laboratories, Inc., Other Asia-Pacific, Category Revenue Share (2011) 63
11.3 Bio-Rad Laboratories, Inc., Europe, Category Revenue Share (2011) 65
11.3.1 Bio-Rad Laboratories, Inc., France, Category Revenue Share (2011) 67
11.3.2 Bio-Rad Laboratories, Inc., Germany, Category Revenue Share (2011) 69
11.3.3 Bio-Rad Laboratories, Inc., Italy, Category Revenue Share (2011) 71
11.3.4 Bio-Rad Laboratories, Inc., Spain, Category Revenue Share (2011) 73
11.3.5 Bio-Rad Laboratories, Inc., United Kingdom, Category Revenue Share (2011) 75
11.3.6 Bio-Rad Laboratories, Inc., Other Europe, Category Revenue Share (2011) 77
11.4 Bio-Rad Laboratories, Inc., Middle East and Africa, Category Revenue Share (2011) 79
11.5 Bio-Rad Laboratories, Inc., North America, Category Revenue Share (2011) 81
11.5.1 Bio-Rad Laboratories, Inc., Canada, Category Revenue Share (2011) 83
11.5.2 Bio-Rad Laboratories, Inc., United States, Category Revenue Share (2011) 85
11.6 Bio-Rad Laboratories, Inc., South and Central America, Category Revenue Share (2011) 87
11.6.1 Bio-Rad Laboratories, Inc., Brazil, Category Revenue Share (2011) 89
11.6.2 Bio-Rad Laboratories, Inc., Other South and Central America, Category Revenue Share (2011) 91
12 Share Holding Structure 93
13 Key Employees 94
14 Key Employee Biographies 95
15 Company Statement 96
16 Locations And Subsidiaries 97
16.1 Head Office 97
16.2 Other Locations & Subsidiaries 97
17 Financial Deals Landscape 100
17.1 Bio-Rad Laboratories, Inc., Deals Volume Summary, 2007 to YTD 2013 100
18 Bio-Rad Laboratories, Inc. Detailed Deal Summary 102
18.1 Asset Purchase 102
18.1.1 Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 102
18.2 Partnerships 103
18.2.1 Chembio Diagnostics Enters Into A Licensing Agreement With Bio-Rad Labs 103
18.2.2 Innogenetics Signs Licensing Agreement With Bio-Rad Labs 104
18.2.3 Bio-Rad Labs Enters Into An Agreement With Axis-Shield 105
18.2.4 Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 106
18.2.5 Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 107
18.2.6 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 108
18.2.7 Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 109
18.2.8 Axis-Shield Signs Option Agreement With Bio-Rad Labs 110
18.2.9 Ariana Pharma Enters Into Collaboration With Bio-Rad Labs, Inserm And Beaujon Hospital 111
18.2.10 Chembio Signs DPP Development Agreement With Bio-Rad Labs 112
18.2.11 Sysmex America Enters Into Co-Marketing Agreement With Bio-Rad Labs 113
18.2.12 Bio-Rad Extends Agreement With Beckman Coulter 114
18.2.13 Bio-Rad Labs Signs Co-Marketing Agreement With Siemens Medical 115
18.2.14 Bio-Rad Labs Completes Public Offering Of Senior Notes Due 2020 For $425 Million 116
18.2.15 Bio-Rad Labs Completes Private Placement Of 8% Senior Subordinated Notes For $300 Million 117
18.3 Acquisition 118
18.3.1 Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For $70 Million 118
18.3.2 Bio-Rad Labs Acquires QuantaLife For $162 Million 120
18.3.3 Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For $0.2 Million 121
18.3.4 Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For $3.4 Million 122
18.3.5 Bio-Rad Labs Acquires Diamed-France 123
18.3.6 Bio-Rad Labs Acquires Additional Stake In Diamed 124
18.3.7 Bio-Rad Labs Completes Acquisition Of Medical Diagnostics Segment From Biotest 125
18.3.8 Bio-Rad Labs Acquires Diamed 127
18.3.9 Bio-Rad Labs Acquires DiaMed Fennica And DiaMed (GB) 128
19 Recent Developments 129
19.1 Strategy And Business Planning 129
19.1.1 Aug 29, 2012: Bio-Rad Opens Digital Biology Center To Develop Products For R&D Markets Based On Its Droplet Digital Technology 129
19.2 Financial Announcements 129
19.2.1 Nov 06, 2012: Bio-Rad Reports Revenue Of $498.7m In Q3 2012 129
19.2.2 Aug 07, 2012: Bio-Rad Reports Revenue Of $510.4m In Q2 2012 130
19.2.3 May 02, 2012: Bio-Rad Reports Revenue Of $486.3m In Q1 2012 131
19.2.4 Feb 23, 2012: Bio-Rad Reports Revenue Of $2.1 Billion In 2011 131
19.2.5 Nov 01, 2011: Bio-Rad Reports Revenues Of $516.5m In Q3 2011 132
19.2.6 Aug 02, 2011: Bio-Rad Reports Revenue Of $521.7m In Q2 2011 133
19.2.7 May 03, 2011: Bio-Rad Reports Net Sales Of $485.1m In Q1 2011 134
19.2.8 Feb 24, 2011: Bio-Rad Reports Net Sales Of $1.9 Billion In 2010 134
19.2.9 Nov 02, 2010: Bio-Rad Reports Net Income Of $44.76 Million For Q3 2010 135
19.2.10 Aug 03, 2010: Bio-Rad Reports Net Income Of $37.95 Million In Q2 2010 136
19.2.11 May 04, 2010: Bio-Rad Reports Net Income Of $34.86 Million In Q1 2010 137
19.2.12 Feb 24, 2010: Bio-Rad Reports Net Income Of $144.6 Million In 2009 138
19.2.13 Nov 03, 2009: Bio-Rad Reports Net Income Of $38.5 Million In Q3 2009 139
19.2.14 Aug 04, 2009: Bio-Rad Reports Net Income Of $37.9 Million In Q2 2009 140
19.2.15 May 05, 2009: Bio-Rad Posts Net Income Of $30.3 Million In Q1 2009 141
19.2.16 Feb 26, 2009: Bio-Rad Posts Net Income Of $89.5 Million For 2008 141
19.2.17 Nov 06, 2008: Bio-Rad Reports 3Q 2008 Results 143
19.2.18 Aug 05, 2008: Bio-Rad Reports 2Q 2008 Results 144
19.2.19 May 06, 2008: Bio-Rad Reports Q1 2008 Results 145
19.2.20 Apr 11, 2008: Bio-Rad To Declare Q1 2008 Results 146
19.2.21 Feb 28, 2008: Bio-Rad Reports Q4 2007 Results 146
19.2.22 Nov 06, 2007: Bio-Rad Reports Q3 2007 Results 148
19.2.23 Oct 11, 2007: Bio-Rad To Announce Q3 2007 Results 149
19.2.24 Aug 07, 2007: Bio-Rad Reports Q2 2007 Results 149
19.2.25 May 03, 2007: Bio-Rad Reports Q1 2007 Results 150
19.2.26 Feb 22, 2007: Bio-Rad Reports Q4 2006 Results 151
19.3 Corporate Communications 152
19.3.1 Nov 01, 2011: Bio-Rad Appoints Deborah J Neff To Board 152
19.3.2 Mar 25, 2010: Bio-Rad Appoints Ted W. Love To Board 152
19.3.3 Oct 07, 2008: Bio-Rad Intent To List On The NYSE 153
19.3.4 Mar 05, 2007: Bio-Rad Announces AMEX Listing Compliance 153
19.3.5 Feb 20, 2007: Bio-Rad Appoints New Board Member 153
19.4 Legal and Regulatory 154
19.4.1 Apr 30, 2012: Vermillion Resolves Non-Contingent Claims With Bio-Rad 154
19.4.2 Aug 13, 2011: GE Healthcare And Bio-Rad Reach Settlement In Label-Free Detection Lawsuit 154
19.5 Product News 155
19.5.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 155
19.5.2 May 17, 2011: Bio-Rad Launches Antiphospholipid Syndrome IgG, IgM, And IgA Kits For BioPlex 2200 System 155
19.5.3 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 156
19.5.4 Oct 13, 2010: Bio-Rad And Axis-Shield Announce FDA Clearance And US Launch Of Anti-CCP Test For Rheumatoid Arthritis For Bio-Rad’s BioPlex 2200 System 157
19.5.5 Jul 26, 2010: Bio-Rad Submits Premarket Approval Application To FDA For GS HIV Combo Ag/Ab EIA 157
19.5.6 Jun 30, 2010: Bio-Rad Introduces IH 1000 Blood Screening System 157
19.5.7 May 24, 2010: Bio-Rad Launches BioPlex 2200 MMRV IgG kit 158
19.5.8 Jan 05, 2010: Axis-Shield And Bio-Rad Introduces BioPlex 2200 Anti-CCP Test For Early Detection Of Rheumatoid Arthritis 158
19.5.9 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 158
19.5.10 Feb 11, 2008: Bio-Rad Launches Vasculitis Kit For Use On The Bioplex 2200 System 159
19.5.11 Nov 13, 2007: Bio-Rad Launches The In2it A1C Analyzer For Point-Of-Care Diabetes Testing 159
19.5.12 Nov 05, 2007: Bio-Rad Introduces Chromogenic Medium In The US For Rapid Screening Of MRSA 159
19.6 Product Approvals 160
19.6.1 Jul 25, 2011: Bio-Rad Receives FDA Premarket Application Approval For GS HIV Combo Ag/Ab EIA 160
19.6.2 Jun 01, 2009: Bio-Rad Laboratories Announces FDA Approval For ToRC IgG And HSV-1 & HSV-2 IgG Kits 160
19.7 Clinical Trials 161
19.7.1 Apr 20, 2011: Researchers Use Bio-Rad’s ProteoMiner Technology To Profile Relative Protein Abundance And Identify Post-Translationally Modified Proteins In Human Saliva 161
19.8 Other Significant Developments 162
19.8.1 Dec 19, 2012: Hospitals, Healthcare Providers To Benefit From New Multi-Source Premier Agreements For Blood Bank Analyzers, Reagents, Consumables And Service 162
20 Appendix 163
20.1 Research Methodology 164
20.2 Secondary Research 164
20.3 Primary Research 164
20.4 Models 165
20.5 Forecasts 165
20.6 Expert Panels 165
20.7 GlobalData Consulting 165
20.8 Currency Conversion 166
20.9 Contact Us 167
20.10 Disclaimer 167


【レポート販売概要】

■ タイトル:Bio-Rad Laboratories, Inc.:市場シェア分析
■ 英文:Bio-Rad Laboratories, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160480
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。